Johnson & Johnson News

Latest Johnson & Johnson News

Disclaimer: IPD Group, the publisher of EIN News, is an independent news monitoring company. There is no affiliation between IPD Group and Johnson & Johnson. EIN News Report: Johnson & Johnson is a media monitoring website that has not been generated, sponsored or otherwise approved by Johnson & Johnson.

Eli Lilly Could Sink On Drug Collusion In India
16 May 18:49 GMT

Recent discoveries have placed Eli Lilly (LLY) in the spotlight for colluding with India's drug regulators. Eli Lilly, along with other Big Pharma names such as GlaxoSmithKline (GSK) and Novartis (NVS), has been colluding with Indian drug regulators …
New Drug May Stop Alzheimer's Before it Starts
16 May 15:50 GMT

Roche Holding AG's Genentech unit has won the right to try its experimental Alzheimer's drug crenezumab on people with no signs of dementia - the first such trial to gauge whether early intervention can help prevent or slow the disease. The drug …
J&J Cancer Drug Zytiga Now Backed For Publicly Funded Use In UK
16 May 09:52 GMT

LONDON – The U.K.'s health-care cost-effectiveness regulator Wednesday reversed an earlier decision and approved the publicly funded use of Johnson & Johnson's (JNJ) prostate-cancer pill Zytiga, after the U.S. company cut its price further. …
Crenezumab: Trial Will Gauge Whether Alzheimer's Drug Can Prevent Or Slow The Disease
15 May 18:51 GMT

* Drug picked from pool of 25 rivals * Study is first prevention trial for Alzheimer's disease * Trial puts major theory of disease to the test By Julie Steenhuysen CHICAGO, May 15 (Reuters) - Roche Holding AG's Genentech unit has won the right to …
Drug makers shifting towards targeted cancer drugs
15 May 16:44 GMT

By Peter Loftus The continuing shift away from one-size-fits-all cancer treatments will be on display this week when a medical society releases clinical data for drugs that target unique molecular features of cancer cells. Pfizer Inc. /quotes/zigman/ …
Roche Alzheimer's drug picked for major test
15 May 16:41 GMT

CHICAGO (Reuters) - Roche Holding AG's Genentech unit has won the right to try its experimental Alzheimer's drug crenezumab on people with no signs of dementia - the first such trial to gauge whether early intervention can help prevent or slow the …
Genentech to test Alzheimer's drug on healthy patients in historic first prevention trial
15 May 16:23 GMT

CHICAGO -- Roche's Genentech unit has won the right to try its experimental Alzheimer's drug crenezumab on people with no signs of dementia -- the first such trial to gauge whether early intervention can help prevent or slow the disease. The drug …
Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the G
15 May 13:08 GMT

NEW YORK, May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical …
Seventh Annual WLSA Convergence Summit Features Innovative Approaches and Technologies to Empower Consumers and ...
15 May 11:47 GMT

Seventh Annual WLSA Convergence Summit Features Innovative Approaches and Technologies to Empower Consumers and Revolutionize Healthcare Delivery and Cost Information contained on this page is provided by companies via press release distributed through PR …
GSK pays $99M to absorb UK-based drug tech firm
15 May 11:28 GMT

Posted May. 15, 2012 at 6:53 a.m. By Staff, wire reports Research Triangle Park, N.C. — GlaxoSmithKline (NYSE: GSK) will pay $99 million to take full control of Cellzome, a closely held company, to boost its drug discovery efforts, the drug giant said …
Article in The Salem News Cautions Consumers of Dangers of Overdosing on Tylenol/Acetaminophen and Risk of Liver Damage, ...
15 May 10:27 GMT

Article in The Salem News Cautions Consumers of Dangers of Overdosing on Tylenol/Acetaminophen and Risk of Liver Damage, the Consumer Justice Foundation Reports (PRWEB) May 15, 2012 The Consumer Justice Foundation, a for-profit corporation whose team of …
Furiex says J&J returns sexual dysfunction drug rights
14 May 22:54 GMT

May 14 (Reuters) - Furiex Pharmaceuticals Inc said its partner Johnson & Johnson returned the worldwide rights for its oral drug to treat premature ejaculation. Furiex said it has licensed the rights of the drug to European pharmaceutical company …
Affinnova's Charu Chaturvedi to Present “Repositioning for Product Success” at the Pharmaceutical Business Intelligence &...
14 May 19:31 GMT

WALTHAM, Mass.--(BUSINESS WIRE)--May 14, 2012 - Affinnova, Inc., the global leader in innovation software and services, announced today that Charu Chaturvedi, Senior Vice President, Affinnova Life Sciences, will make a presentation on “Repositioning for …
Yield, Value, Safety: Are They Still Available For Big Pharma? (Part 1)
14 May 16:58 GMT

"We had it once, we ain't got it anymore … don't you feel like you're a rider, on a downbound train?" -- "Downbound Train," Bruce Springsteen (1984). These phrases, lifted from the mournful Springsteen tune named above, …
Tenet Healthcare Appoints Daniel Waldmann As SVP Of Public Affairs
14 May 15:27 GMT

5/14/2012 9:07 AM ET (RTTNews) - Tenet Healthcare Corp. (THC: News ) said it named Daniel Waldmann senior vice president of public affairs. In this new role reporting to Tenet's president and CEO, Waldmann will oversee the company's public affairs …
JNJ -Study Reports Catheter Ablation Superior to Drug Therapy as First-Line Treatment for Atrial Fibrillation
14 May 15:21 GMT

JNJ -Study Reports Catheter Ablation Superior to Drug Therapy as First-Line Treatment for Atrial Fibrillation ENP Newswire - 14 May 2012 Release date- 11052012 - Boston, Mass. - -Patients with the heart rhythm disorder atrial fibrillation (AFib) who …
A Health Care Fortnight for the Record Books
14 May 15:02 GMT

NEW YORK (TheStreet) -- I've been a professional investor for 15 years, and over that time I've listened to generalist investors gripe about the health care sector with mind-numbing cyclicality. Predictably, interest in health care investing often …
4 Pharmaceuticals To Consider In A Highly Volatile Market
14 May 14:29 GMT

Companies operating within the pharmaceuticals sector rely heavily on the success of their current drugs, and having a strong drug pipeline. Likewise, patent expiration is a major hurdle for many pharmaceuticals that don't have a large product …
Johnson & Johnson Dividend Stock Analysis
14 May 14:29 GMT

Linked here is a detailed quantitative analysis of Johnson & Johnson (JNJ). Below are some highlights from the above linked analysis: Company Description: Johnson & Johnson is a leader in the pharmaceutical, medical device and consumer products …
The Zacks Analyst Blog Highlights: Covidien, General Electrical, Becton, Dickinson and Company, Johnson and Johnson and ...
14 May 13:56 GMT

… and Company (NYSE:BDX), Johnson and Johnson (NYSE:JNJ) and CR Bard Inc. (NYSE … easily accessible to clinicians and healthcare administrators. Following this collaboration, GE … and Company (NYSE:BDX), Johnson and Johnson (NYSE:JNJ) and CR Bard Inc. (NYSE …
Why Johnson & Johnson Looks Better Than Its Competitors
13 May 21:36 GMT

There have been several changes for Johnson & Johnson (JNJ) recently, but the question for investors is whether or not these changes are for the better. When former CEO William Weldon stepped down from his position of joint CEO and company Chairman to …

1 2 3 4 5 6 7 8 9 10 Next

EIN NEWS REPORT: JOHNSON & JOHNSON			BACK TO TOP

Account Info:

My Account
Subscriber Billing Info
Member Center
- Change your billing and/or user information
- Extend your subscription period
- Re-activate an expired account
- Manage your Email Alerts
- Add additional users to your account
- Manage your additional user account(s)
- Retrieve a lost password
- Get an invoice for your subscription
- Cancel your account by sending us an email through the feedback form

Create an Account:

Help & Information Center:

Submit

About

Navigate:

Tools and Formats:

EIN News Home
About EIN News

Founded in 1995, EIN News is an international leader in real-time news tracking and digital information services. Our systems continuously scan the web, indexing news from thousands of worldwide sources. The data is then filtered and organized into news streams. The process is supervised by a team of professional news editors.

We are news professionals and technologists dedicated to producing the fastest and most comprehensive news streams on the planet. We are committed to providing our members with the highest quality software tools and resources available.

EIN News is a division of Internet Product Development Group Inc.
To reach us send an email or call +1 202 657 5158.
EIN Presswire
EIN Marketplace
EIN Events and Conferences
Newsfeed Maker
Inbox Robot
IPD Group
EIN Twitter
EIN Facebook

= Unlimited access to real-time news

Create your EIN News account now.

ALL NEWS PUBLICATIONS

EIN News provides breaking news coverage on the following topics: